AMGN vs TDG · P/E 24, rev $10.05B vs P/E 41, rev $8.83B
Amgen Inc (AMGN) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the AMGN and TDG stock pages for the full models.
Not investment advice.